Lucio Tozzi
Chief Tech/Sci/R&D Officer chez RAIN ONCOLOGY INC.
Profil
Lucio Tozzi's current job(s) include Senior Vice President-Clinical Operations at Rain Oncology, Inc. since 2021 and Senior Vice President-Global Clinical Operations at ProKidney Corp.
since 2024.
Formerly, Mr. Tozzi worked as Director-Clinical Operations at Baxter Healthcare Corp.
from 2005 to 2014, Senior Medical Director-Clinical Science at Onyx Pharmaceuticals, Inc. from 2008 to 2012, Senior Director & Head-Clinical Operations at Astex Pharmaceuticals, Inc. from 2014 to 2015, Vice President-Clinical Operations at Protagonist Therapeutics, Inc. from 2015 to 2019, and as Principal-Clinical Research Services at Parkwood Advisors LLC in 2014.
Mr. Tozzi obtained his undergraduate degree from Royal Holloway University of London in 1986.
Postes actifs de Lucio Tozzi
| Sociétés | Poste | Début |
|---|---|---|
| RAIN ONCOLOGY INC. | Chief Tech/Sci/R&D Officer | 01/05/2019 |
| PROKIDNEY CORP. | Chief Tech/Sci/R&D Officer | 22/01/2024 |
Anciens postes connus de Lucio Tozzi
| Sociétés | Poste | Fin |
|---|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/05/2019 |
Astex Pharmaceuticals, Inc.
 Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded on May 28, 1997 and is headquartered in Pleasanton, CA. | Chief Tech/Sci/R&D Officer | 01/07/2015 |
| Parkwood Advisors LLC | Corporate Officer/Principal | 01/08/2014 |
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Chief Tech/Sci/R&D Officer | 01/01/2014 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 01/06/2012 |
Formation de Lucio Tozzi
| Royal Holloway University of London | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Health Technology |
| PROKIDNEY CORP. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded on May 28, 1997 and is headquartered in Pleasanton, CA. | Health Technology |
Rain Oncology, Inc.
 Rain Oncology, Inc. BiotechnologyHealth Technology Rain Oncology, Inc. is a clinical-stage precision oncology company, which focuses on developing and implement the precision oncology therapies for patients suffering from cancer. The company was founded by Avanish Vellanki and Robert Doebele in April 2017 and is headquartered in Newark, CA. | Health Technology |
| Parkwood Advisors LLC |
